Senior insider sale
Chief Commercial Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$403.9K
9.39K shares
What this filing means
HEERMA PETER plans to sell 9.39K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $403.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/5/2026ACC: 0001193125-26-207078
Officer· Chief Commercial Officer
Since Oct 2019
9.39K
Shares to sell
$403.9K
Approx. market value
2.17K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Performance Restricted Stock Unit Vesting
Compensation
5/4/2026
2.17KTotal acquired2.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2026 | Performance Restricted Stock Unit Vesting Compensation | 2.17K | — |
| Total | 2.17K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.21K
Market value
$302.5K
4/14/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.17K
Market value
$101.4K
5/5/2026
Total
Units
9.39K
Value
$403.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/14/2026 | 7.21K | $302.5K | — | Completed |
| Planned — Approximate Date | ||||
5/5/2026 | 2.17K | $101.4K | NASDAQ | Planned |
| Total | 9.39K | $403.9K | ||